Investigational drug · Phase 3
rebonuputemcel
Also called: IDCT
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Degenerative Disc Disease.
Phase 3Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "rebonuputemcel"
First trial start
2025
Dec 23, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "rebonuputemcel", any sponsor or status.
Conditions studied
As listed on its trial records.
- Degenerative Disc Disease
Largest trials
Live from ClinicalTrials.gov: studies naming "rebonuputemcel" as an intervention, largest first.
- A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc DiseasePivotal-lookingRecruiting
DiscGenics, Inc.Industry
NCT07254806 · 162 participants (planned) · Start Dec 23, 2025 · Primary completion Nov 24, 2027
Drug: IDCT (rebonuputemcel) · For: Degenerative Disc Disease
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 31 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Genomic and clinicopathologic analysis of conventional dendritic cell sarcomas coexisting with myeloid neoplasms.
Yoshikawa K, Seki M, Sakakibara A, et al. · Virchows Arch 2026
- Multiple Pruritic Papules and Nodules in a 50-Year-Old Woman: Answer.
Makhija M, Robinson J, Van Vliet C, et al. · Am J Dermatopathol 2026
- Inducible displacement CT for implant loosening detection: a scoping review on methods, validation, and challenges.
Ter Wee MA, Dobbe JGG, Kievit AJ, et al. · Acta Orthop 2026
- Query-efficient decision-based adversarial attack with low query budget.
Tuo Y, Yin M, Che S · Sci Rep 2026
- Incremental Vision-Language Object Detection via Sparse Frequency Transform.
Song X, Yang Z, He Y, et al. · IEEE Trans Image Process 2026
- Widespread Cutaneous Indeterminate Dendritic Cell Tumor (IDCT) With ETV3::NOAC2 Rearrangement Successfully Treated With PUVA Therapy: A Case Report.
Deshpande A, Rudzki Z, Bhat J, et al. · Case Rep Hematol 2024
Also in development for Degenerative Disc Disease
- CELZ-201-DDTPhase 21 trial
Creative Medical Technology Holdings Inc · Chronic Low-back Pain, Degenerative Disc Disease
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.